Table 1.
Demographic and Clinical/Radiologic Characteristics of 22 Patients at Study Entry
| Characteristic | Patients, No. (%) |
|---|---|
| Age, median (range), y | 64 (50–76) |
| Sex | |
| Male | 10 (45) |
| Female | 12 (55) |
| Race | |
| White | 21 (95) |
| Black | 1 (5) |
| ECOG performance status | |
| 0 | 14 (64) |
| 1 | 8 (36) |
| Serum CA 19-9, median (range), U/mL | 122 (0–910) |
| Tumor diameter, median (range), mm | 30 (16–49) |
| Radiographic tumor-vessel interfacea | |
| Vein onlyb | 6 (27) |
| <180° | 0 (0) |
| ≥180° | 6 (27) |
| Artery onlyc | 3 (14) |
| <180° | 3 (14) |
| ≥180° | 0 (0) |
| Artery and veinb,c | 13 (59) |
| Artery <180°, vein <180° | 6 (27) |
| Artery <180°, vein ≥180° | 6 (27) |
| Arteryd ≥180°, vein <180° | 1 (5) |
Abbreviations: ECOG, Eastern Cooperative Oncology Group; CA 19-9, carbohydrate antigen.
a
On central review, all vessels were patent, and no patient had a radiologic interface between the tumor and 180° or more of the superior mesenteric artery.
b
Portal vein and/or superior mesenteric vein.
c
Superior mesenteric artery, hepatic artery, or celiac trunk.
d
Common hepatic artery.